Ideal Injection Points for Botulinum Neurotoxin for Pectoralis Minor Syndrome: A Cadaveric Study

Toxins (Basel). 2023 Oct 7;15(10):603. doi: 10.3390/toxins15100603.

Abstract

Pectoralis Minor Syndrome (PMS) causes significant discomfort due to the compression of the neurovascular bundle within the retropectoralis minor space. Botulinum neurotoxin (BoNT) injections have emerged as a potential treatment method; however, their effectiveness depends on accurately locating the injection site. In this study, we aimed to identify optimal BoNT injection sites for PMS treatment. We used twenty-nine embalmed and eight non-embalmed human cadavers to determine the origin and intramuscular arborization of the pectoralis minor muscle (Pm) via manual dissection and Sihler's nerve staining techniques. Our findings showed the Pm's origin near an oblique line through the suprasternal notch, with most neural arborization within the proximal three-fourths of the Pm. Blind dye injections validated these results, effectively targeting the primary neural arborized area of the Pm at the oblique line's intersection with the second and third ribs. We propose BoNT injections at the arborized region within the Pm's proximal three-fourths, or the C region, for PMS treatment. These findings guide clinicians towards safer, more effective BoNT injections.

Keywords: Pectoralis Minor Syndrome; Sihler staining; botulinum neurotoxin; pectoralis minor muscle; thoracic outlet syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Botulinum Toxins* / therapeutic use
  • Botulinum Toxins, Type A*
  • Cadaver
  • Humans
  • Injections
  • Injections, Intramuscular
  • Pectoralis Muscles / innervation

Substances

  • Botulinum Toxins
  • Botulinum Toxins, Type A

Grants and funding

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2019R1C1C1010776 and 2022R1I1A1A01069499). No other external funding or competing interests are declared.